news AstraZeneca and Celgene collaborate to develop MEDI4736 for patients with serious blood cancers 24 April 2015 | By Victoria White AstraZeneca and Celgene collaborate for the development and commercialisation of MEDI4736 across a range of blood cancers, including non-Hodgkin’s lymphoma...
news International consortium CANCER-ID to develop novel biomarker technologies in cancer 23 April 2015 | By Victoria White Bayer and UKE are the main coordinators of a new international consortium, CANCER-ID, to develop novel blood-based biomarker technologies in cancer...
news New research describes blueprint for truly personalised cancer immunotherapies 23 April 2015 | By Victoria White An article describing an important scientific foundation for the clinical development of truly personalised cancer immunotherapies has been published...
news ImmuneXcite presents new preclinical data on its mAbXcite platform 22 April 2015 | By Victoria White New preclinical data demonstrates that mAbXcite therapies causes an immune cascade that successfully recruits T-cells to mount an attack against cancer...
news ARIAD announces results of preclinical studies on brigatinib at AACR 2015 22 April 2015 | By Victoria White ARIAD has announced the results of a series of preclinical studies on its investigational tyrosine kinase inhibitor, brigatinib (AP26113), at AACR 2015...
news Epizyme presents preclinical research on CARM1 and PRMT6 21 April 2015 | By Victoria White Epizyme has presented data on two epigenetic targets, CARM1 and PRMT6, in its pioneering therapeutic pipeline at the AACR Annual Meeting 2015...
news Trial shows benefit of ‘BRCA-targeting’ drug, olaparib, in prostate cancer 21 April 2015 | By Victoria White Men with prostate cancer benefit from treatment with the pioneering drug olaparib according to the results of a major trial presented today...
news Transgene presents preclinical data for TG4010 and TG3003 at AACR 2015 21 April 2015 | By Victoria White Transgene has announced that new preclinical data for two of its programmes – TG4010 and TG3003 – were presented at the Annual Meeting of the AACR...
news Results announced from a preclinical study of AV-380 for the treatment of cancer associated cachexia 20 April 2015 | By Victoria White Results from a preclinical study of AV-380, a GDF15 inhibitory antibody for the treatment of cancer associated cachexia, have been presented at AACR 2015...
news Positive preclinical data on IRAK4 inhibitor compounds presented at AACR 2015 20 April 2015 | By Victoria White Preclinical data demonstrating single agent and combination activity of two of TG Therapeutics’ IRAK4 inhibitor compounds has been presented AACR 2015...
news DelMar presents positive preclinical data on VAL-083 for treatment of non-small cell lung cancer 20 April 2015 | By Victoria White DelMar Pharmaceuticals presented positive preclinical data on its lead product candidate VAL-083 for treatment of platinum drug-resistant NSCLC at AACR2015...
news Blueprint Medicines presents preclinical data demonstrating significant anti-tumour activity of BLU-285 in treatment-resistant GIST 20 April 2015 | By Victoria White New preclinical data demonstrates that BLU-285 has significant anti-tumour activity in treatment-resistant models of gastrointestinal stromal tumours (GIST)...
news Peloton Therapeutics presents promising data on PT2385, the first Inhibitor of HIF-2a for renal cell carcinoma 20 April 2015 | By Victoria White Peloton presented promising preclinical data on PT2385, the first Inhibitor of HIF-2a for renal cell carcinoma, at AACR 2015...
news Novogen and the Feinstein Institute collaborate to develop effective treatments for brain cancers 17 April 2015 | By Victoria White Novogen and the Feinstein Institute for Medical Research are to collaborate to develop effective treatments for brain cancers...
news CiRA and Takeda to collaborate on iPS Cell Research 17 April 2015 | By Victoria White Takeda and CiRA to work together to develop clinical applications of induced pluripotent stem cells in areas such as diabetes mellitus and immunotherapy...